Skip to main content
. 2017 May 5;5(2):23. doi: 10.3390/healthcare5020023

Table 1.

ACT-IN components, targets, and outcomes.

Measure Construct Assessed Method Time Points
Screening and Diagnosis
Mini-Mental state Exam (MMSE) [49] Cognitive impairment Interviewer BL
Structured Clinical Interview for DSM-IV (SCID) [48] Axis I diagnosis Interviewer BL
Psychiatric Symptoms
Brief Psychiatric Rating Scale (BPRS) [45,82] Psychiatric symptoms Interviewer BL,DC,4
Clinical Outcomes in Routine Evaluation (CORE) [83] Psychiatric symptoms Self-Report BL,DC,4
Functioning
Heinrichs Brief Quality of Life Scale [84] Quality of Life Interviewer BL,DC,4
WHO Disability Assessment Schedule (WHODAS)-12 [85] Psychosocial Functioning Self-Report BL,DC,4
Schizophrenia-Quality of Life-18 (S-QOL-18) [86] Quality of Life Self-Report BL,DC,4
Treatment Adherence/Utilization
Brief Adherence Rating Scale (BARS) [87] Medication adherence Interviewer 4
Treatment History Interview-4 (THI-4) [88] Treatment utilization Interviewer 4
Mechanisms Measures
Cognitive and Affective Mindfulness Scale-Revised Mindfulness Self-report BL,DC,4
Acceptance and Action Questionnaire-II (AAQ-II) [61,89] Psychological acceptance Self-report BL,DC,4
Valuing Questionnaire (VQ) [90] Values-consistent living Self-report BL,DC,4
Acceptability/Satisfaction
Client Satisfaction Questionnaire-8 (CSQ-8) [91] Treatment satisfaction Self-report DC
Qualitative Post-Treatment Interview Treatment satisfaction Interview DC

Note: BL = Baseline, DC = Discharge, 4 = 4 Month Follow-up.